Arrakis Therapeutics' Series A Round

Arrakis Therapeutics raised a round of funding on February 27, 2017.

Arrakis Therapeutics is developing proprietary discovery platforms comprised of a high-throughput, comprehensive system of bioinformatics tools, assays and chemical libraries that can identify new rib…

Articles about Arrakis Therapeutics' Series A Round: